SEC Form 4 · accession 0001209191-17-049129
BioAmber Inc. · BIOA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Fabrice Orecchioni
Officer — Chief Operations Officer
Period of report
Aug 15, 2017
Accepted (ET)
Aug 16, 2017 · 1:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001534287
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 15, 2017 | P$0 | 26,666 | — | A | 27,766 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Warrants (right to buy)F1 | $0.75 | Aug 15, 2017 | P | 26,666 | A | Aug 15, 2017 | Aug 15, 2022 | Common Stock | 26,666 | 26,666 | D |
Explanation of responses
- F1The fixed combination, consisting of one share of common stock and associated warrant to purchase one share of common stock was issued at a price of $0.75.